MDGL — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

9.58

Margin Of Safety %

Put/Call OI Ratio

0.57

EPS Next Q Diff

-1.31

EPS Last/This Y

6.36

EPS This/Next Y

16.12

Price

509.58

Target Price

678.18

Analyst Recom

1.16

Performance Q

-4.64

Upside

-188.4%

Beta

-1

Ticker: MDGL

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-07-14	MDGL	536.74	0.40	0.30	18142
2026-07-15	MDGL	549.31	0.40	0.33	18204
2026-07-16	MDGL	545.59	0.41	0.42	18336
2026-07-17	MDGL	553.79	0.41	0.52	18374
2026-07-20	MDGL	535.96	0.43	1.22	10217
2026-07-21	MDGL	546.21	0.43	0.41	10474
2026-07-22	MDGL	536.83	0.43	2.25	10587
2026-07-23	MDGL	543.62	0.43	3.54	10625
2026-07-24	MDGL	544.81	0.46	0.28	10876
2026-07-27	MDGL	551.25	0.46	0.12	10982
2026-07-28	MDGL	538.54	0.45	0.17	11028
2026-07-29	MDGL	546.23	0.45	1.42	11108
2026-07-30	MDGL	492.94	0.46	1.06	11217
2026-07-31	MDGL	467.39	0.51	0.85	12499
2026-08-03	MDGL	482.19	0.54	0.42	13136
2026-08-04	MDGL	507.56	0.53	0.11	13330
2026-08-05	MDGL	513.96	0.54	5.21	13249
2026-08-06	MDGL	509.02	0.57	0.20	13465
2026-08-07	MDGL	508.7	0.57	0.10	13393
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-07-14	MDGL	536.80	-17.4	-	-6.52
2026-07-15	MDGL	550.27	-17.4	-	-6.52
2026-07-16	MDGL	544.15	-17.4	-	-6.52
2026-07-17	MDGL	553.31	-17.4	-	-6.52
2026-07-20	MDGL	536.03	-17.4	-	-6.52
2026-07-21	MDGL	547.32	-17.4	-	-6.52
2026-07-22	MDGL	536.87	-17.4	-	-6.52
2026-07-23	MDGL	543.48	-17.4	-	-6.52
2026-07-24	MDGL	544.69	-17.4	-	-6.52
2026-07-27	MDGL	551.25	-17.4	-	-6.52
2026-07-28	MDGL	538.70	-17.4	-	-6.52
2026-07-29	MDGL	546.81	-17.4	-	-6.52
2026-07-30	MDGL	492.35	-17.4	-	-6.52
2026-07-31	MDGL	467.55	-17.4	-	-6.52
2026-08-03	MDGL	482.19	-17.4	-	-6.52
2026-08-04	MDGL	482.19	-17.4	-	-6.52
2026-08-05	MDGL	513.82	73.7	-	-7.17
2026-08-06	MDGL	510.55	73.7	-	-7.17
2026-08-07	MDGL	509.58	78.1	-	-6.49
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-07-14	MDGL	-1.42	2.98	16.27
2026-07-15	MDGL	-1.42	2.98	16.27
2026-07-16	MDGL	-1.42	2.98	16.27
2026-07-17	MDGL	-1.42	2.98	16.27
2026-07-20	MDGL	-1.42	3.02	16.27
2026-07-21	MDGL	-1.39	3.02	16.27
2026-07-22	MDGL	-1.39	3.02	16.27
2026-07-23	MDGL	-1.39	3.02	16.27
2026-07-24	MDGL	-1.39	3.02	16.27
2026-07-27	MDGL	-1.02	3.11	9.60
2026-07-28	MDGL	-1.02	3.11	9.60
2026-07-29	MDGL	-1.02	3.11	9.60
2026-07-30	MDGL	-1.02	3.11	9.60
2026-07-31	MDGL	-1.02	3.11	9.60
2026-08-03	MDGL	-1.02	0.48	9.58
2026-08-04	MDGL	-1.02	0.48	9.58
2026-08-05	MDGL	-1.02	0.48	9.58
2026-08-06	MDGL	-1.02	0.48	9.58
2026-08-07	MDGL	-1.02	0.48	9.58
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

0.89

Avg. EPS Est. Current Quarter

-1.09

Avg. EPS Est. Next Quarter

-0.42

Insider Transactions

-1.02

Institutional Transactions

0.48

Beta

-1

Average Sales Estimate Current Quarter

403

Average Sales Estimate Next Quarter

442

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

17.1

Max Drawdown 5-Year %

-61.4

Target Price

678.18

P/E

Forward P/E

77.86

PEG

P/S

9.18

P/B

22.49

P/Free Cash Flow

EPS

-12.88

Average EPS Est. Cur. Y

-6.49

EPS Next Y. (Est.)

9.62

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-25.32

Relative Volume

0.96

Return on Equity vs Sector %

-89.4

Return on Equity vs Industry %

-73.3

EPS 1 7Days Diff

EPS 1 30Days Diff

0.03

EBIT Estimation

◆ MDGL Healthcare

$510.04

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

14/20

Pullback

15/25

Volume

4/15

Valuation

11/20

TP/AR

2/10

Options

7/10

RSI

46.7

Range 1M

50.6%

Sup Dist

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

7/25

Growth

22/30

Estimates

1/20

Inst/Vol

4/15

Options

7/10

EPS Yr

51.3%

EPS NY

204.6%

52W%

61.5%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🔴 SELL -14.9% upside

Quality

6/30

Valuation

0/30

Growth

15/25

Stability

6/10

LT Trend

1/5

Upside

-14.9%

Quality

MDGL — P/E HistoricalBiotechnology

Madrigal Pharmaceuticals, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 915

Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.

MDGL

Latest News

—

Caricamento notizie per MDGL…

stock quote shares MDGL – Madrigal Pharmaceuticals Inc Stock Price stock today

news today MDGL – Madrigal Pharmaceuticals Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch MDGL – Madrigal Pharmaceuticals Inc yahoo finance google finance

stock history MDGL – Madrigal Pharmaceuticals Inc invest stock market

stock prices MDGL premarket after hours

ticker MDGL fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: MDGL

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y